SCHEMBL5214

SCHEMBL5214

COCCCc1ccc(N2CC[C@]3(CC[C@@](O)(C(C)C)CC3)C2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.40
CYP3A4 P08684 9/20 0.37
CYP2C19 P33261 3/20 0.37
TSHR P16473 2/20 0.37
USP2 O75604 4/20 0.37
ALDH1A1 P00352 4/20 0.37
HSD17B10 Q99714 3/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2C9 P11712 3/20 0.37
HPGD P15428 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPK1 P28482 3/20 0.35
ACACB O00763 1/20 0.35
KCNH2 Q12809 1/20 0.34
ALOX15 P16050 1/20 0.34
HIF1A Q16665 1/20 0.34
CYP2D6 P10635 2/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5166 0.80 CYP3A4 (0.37) S1PR1CYP3A4CYP2C19TSHRUSP2
SCHEMBL5165 0.80 CYP3A4 (0.37) S1PR1CYP3A4CYP2C19TSHRUSP2
SCHEMBL5639 0.76 S1PR1 (0.41) S1PR1CYP3A4CYP2C19TSHRUSP2
SCHEMBL5569 0.76 USP2 (0.41) CYP3A4CYP2C19TSHRUSP2ALDH1A1
SCHEMBL5479 0.76 LIPE (0.46) S1PR1
SCHEMBL5548 0.74 CYP3A4 (0.36) CYP3A4CYP2C19TSHRUSP2ALDH1A1
SCHEMBL4617 0.73 CYP3A4 (0.42) CYP3A4CYP2C19TSHRUSP2HSD17B10
SCHEMBL5301 0.73 EPHX2 (0.42) KCNH2
SCHEMBL17897273 0.73 S1PR1 (0.38) S1PR1ALDH1A1SMN1; SMN2
SCHEMBL17898052 0.71 S1PR1 (0.39) S1PR1KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed